WDFY3 and ovarian carcinoma: As an upregulated lncRNA in cisplatin-resistant ovarian cancer cells, WDFY3-AS2 increases tumorspheres via the WDFY3-AS2/miR-139-5p/SDC4 axis (Wu et al., 2021[139]).